NextFin News -
Pre-Market Performance
U.S. index futures were mixed, with technology futures under modest pressure while blue-chip futures held slightly positive. Nasdaq 100 futures traded at 29,222.3, down 54.5 points or 0.19%; S&P 500 futures were at 7,688.0, down 4.0 points or 0.05%; Dow futures were at 53,665.0, up 20.0 points or 0.04%.
European markets were broadly firmer. The FTSE 100 rose 6.81 points, or 0.06%, to 10,892.97; France's CAC 40 gained 48.10 points, or 0.57%, to 8,487.30; Germany's DAX advanced 71.36 points, or 0.27%, to 26,337.50.
In commodities and FX, energy remained the key mover: WTI crude traded near $80.58, down $1.78 or 2.16%, while Brent crude was around $85.54, down $1.73 or 1.98%. Gold futures were at $4,679.80, down $14.70 or 0.31%. The U.S. Dollar Index stood near 98.918, up 0.080 or 0.08%.
Hot News
- U.S. futures pause ahead of Nvidia's results. U.S. equity futures were subdued as investors waited for Nvidia's quarterly report, a central test for the AI-led equity rally. A Reuters report noted that futures were little changed, with Nasdaq futures lagging as traders assessed whether AI-related earnings momentum can continue. Read more
- Oil slides as Hormuz talks revive supply hopes. Crude prices fell sharply after Iran said it had restarted talks with Oman on managing traffic through the Strait of Hormuz. The move eased immediate supply-risk pricing across energy markets. Read more
- European equities edge higher as lower oil supports sentiment. European shares advanced as the drop in crude prices helped ease pressure on yields and inflation-sensitive sectors. Investors remained focused on Nvidia's earnings as a global AI sentiment barometer. Read more
- U.S.-Canada tariff dispute remains a market risk. Canada announced retaliatory measures after new U.S. tariffs deepened the trade dispute between the two countries. The escalation keeps industrials, autos, materials and consumer-linked supply chains in focus. Read more
- Gold holds near elevated levels despite a firmer dollar. Gold remained close to recent highs as investors balanced lower oil prices, geopolitical uncertainty and a still-cautious rates backdrop. Read more
U.S. Stock Focus
- Nvidia — Earnings report is the central AI catalyst. Nvidia reports after the close, with consensus expectations around $91.9 billion in revenue and $2.08 in EPS. The result is expected to set the tone for AI infrastructure, semiconductors and megacap technology sentiment. Read more
- Intuit — Shares slide after conservative fiscal 2027 outlook. Intuit fell sharply after hours despite fourth-quarter results that beat estimates, as investors focused on softer full-year guidance. The company projected fiscal 2027 adjusted EPS of $22.88 to $23.12, below the $27.34 consensus, while revenue guidance of $23.28 billion to $23.51 billion also trailed expectations. Read more
- Semtech — Stock gains on AI data-center networking strength. Semtech rose after reporting adjusted EPS of $0.71 on revenue of $341.9 million, ahead of expectations. Management guided current-quarter revenue to $405 million to $415 million and EPS to $1.02 to $1.08, supported by strong AI data-center networking demand. Read more
- Spyre Therapeutics — Phase 2 trial disappointment pressures shares. Spyre Therapeutics dropped after reporting that its Phase 2 SKYWAY trial evaluating SPY072 in rheumatoid arthritis failed to meet its internal efficacy threshold for advancement as a monotherapy. The clinical update weighed heavily on the biotech's after-hours trading. Read more
- Zoom Video Communications — Post-earnings profit-taking follows modest beat. Zoom shares declined after hours even though the company posted EPS of $1.55 on revenue of $1.28 billion. Investors focused on normalized growth trends in the core online segment despite management lifting fiscal 2027 revenue guidance to $5.09 billion to $5.10 billion. Read more
- nCino — Guidance raises concerns over sales cycles. nCino fell after reporting adjusted EPS of $0.05 on revenue of $161 million. The company's third-quarter revenue outlook of $161.25 million to $163.25 million barely matched expectations, raising concern over lengthening sales cycles among regional banking clients. Read more
- McKesson — Precision Medicine deal supports oncology strategy. McKesson remained in focus after announcing a definitive agreement to acquire Precision Medicine Group in a transaction valued at about $2.25 billion. The deal expands McKesson's exposure to clinical research, biomarker intelligence and biopharma commercialization services. Read more
- Salesforce — Earnings due after the close. Salesforce is scheduled to report after the market closes, with consensus centered on revenue near $11.33 billion and EPS around $3.27. Investors will focus on AI product monetization, margin discipline and enterprise software demand. Read more
- CrowdStrike — Cybersecurity demand and ARR trends in focus. CrowdStrike also reports after the close, with market expectations near $1.44 billion in revenue and EPS around $0.29. The key focus will be subscription momentum, annual recurring revenue trends and demand for AI-linked security modules. Read more
Explore more exclusive insights at nextfin.ai.
